Panel consensus - Putting it together: A new treatment algorithm for vasovagal syncope and related disorders

American Journal of Cardiology

Volumn 84, Issue 8 SUPPL. 1, 1999, Pages 33-39

  Bloomfield, Daniel M ^a   Sheldon, Robert ^b   Grubb, Blair P ^c   Calkins, Hugh ^d   Sutton, Richard ^e  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; MIDODRINE;

ALGORITHM; ANAMNESIS; AUTONOMIC DYSFUNCTION; CLINICAL PROTOCOL; HUMAN; ORTHOSTATIC HYPERTENSION; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SALT INTAKE; STANDING; SYNCOPE; TACHYCARDIA; TILT TABLE TEST; TREATMENT PLANNING; AUTONOMIC NEUROPATHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; PRACTICE GUIDELINE;

ALGORITHMS; AUTONOMIC NERVOUS SYSTEM DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRACTICE GUIDELINES; SYNCOPE, VASOVAGAL; TILT-TABLE TEST;

EID: 0033592525     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(99)00694-3     Document Type: Review

References (42)

1. Kenny R.A., Bayliss J., Ingram A., Sutton R. Head-up tilt a useful test for investigating unexplained syncope . Lancet. 1:1986;1352-1355.
2. Ward C.R., Gray J.C., Gilroy J.J., Kenny R.A. Midodrine a role in the management of neurocardiogenic syncope . Heart. 79:1998;45-49.
3. Raviele A., Brignole M., Sutton R., Alboni P., Giani P., Menozzi C., Moya A. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope a double-blind, randomized, placebo-controlled trial: The Vasovagal Syncope International Study . Circulation. 99:1999;1452-1457.
4. Mahanonda N., Bhuripanyo K., Kangkagate C., Wansanit K., Kulchot B., Nademanee K., Chaithiraphan S. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J. 130:1995;1250-1253.
5. Connolly S.J., Sheldon R., Roberts R.S., Gent M. The North American Vasovagal Pacemaker Study (VPS) a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope . J Am Coll Cardiol. 33:1999;16-20.
6. Di Girolamo E, Di Iorio C, Sabatini P., Leonzio L., Barbone C., Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope a randomized, double-blind, placebo-controlled study . J Am Coll Cardiol. 33:1999;1227-1230.
7. Zeng C., Zhu Z., Liu G., Hu W., Wang X., Yang C., Wang H., He D., Tan J. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J. 136:1998;852-858.
8. Grubb B.P., Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance an overview of classification, clinical evaluation, and management . PACE Pacing Clin Electrophysiol. 22:1999;798-810.
9. Benditt D.G. Neurally mediated syncopal syndromes pathophysiological concepts and clinical evaluation . PACE Pacing Clin Electrophysiol. 20:1997;572-584.
10. Sutton R., Petersen M.E. The economics of treating vasovagal syncope. PACE Pacing Clin Electrophysiol. 20:1997;849-850.
11. Grubb P.B. Pathophysiology and differential diagnosis of neurocardiogenic syncope a brief review . Am J Cardiol. 84:1999;3Q-9Q.
12. Bloomfield D., Maurer M., Bigger J.T.J. Effects of age on outcome of tilt-table testing. Am J Cardiol. 83:1999;1055-1058.
13. Fitzpatrick A.P., Theodorakis G., Vardas P., Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 17:1991;125-130.
14. Oberg B., Thoren P.N. Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat - a possible cause of the vasovagal reaction. Acta Physiol Scand. 85:1972;164-173.
15. Streeten D.H.P., Anderson G.H. Delayed orthostatic intolerance. Arch Intern Med. 152:1992;1066-1072.
16. Linzer M., Pontinen M., Gold D.T., Divine G.W., Felder A., Brooks W.B. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 44:1991;1037-1043.
17. Rose S., Koshman M.L., McDonald S., Sheldon R. Health-related quality of life in patients with neuromediated syncope. (Abstr.) Can J Cardiol. 12:1996;131E.
18. Sheldon R., Koshman M.L., Wilson W., Kieser T., Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol. 81:1998;158-162.
19. Grimm W., Degenhardt M., Hoffman J., Menz V., Wirths A., Maisch B. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J. 18:1997;1465-1469.
20. Natale A., Geiger M.J., Maglio C., Newby K.H., Dhala A., Akhtar M., Sra J. Recurrence of neurocardiogenic syncope without pharmacologic interventions. Am J Cardiol. 77:1996;1001-1003.
21. Sheldon R., Rose S., Flanagan P., Koshman M.L., Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation. 93:1996;973-981.
22. Malik P., Koshman M.L., Sheldon R. Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result. J Am Coll Cardiol. 29:1997;1284-1289.
23. Brignole M., Menozzi C., Gianfranchi L., Bottoni N., Lolli G. The clinical and prognostic significance of the asystolic response during the head-up tilt test. Eur J Pacing Electrophysiol. 2:1992;109-113.
24. Davidson E., Fuchs J., Rotenberg Z., Weinberger I., Agmon J. Drug-related syncope. Clin Cardiol. 12:1989;577-580.
25. Morillo C.A., Leitch J.W., Yee R., Klein G.J. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally-mediated syncope induced by head-up tilt. J Am Coll Cardiol. 22:1993;1843-1848.
26. Brignole M., Menozzi C., Gianfranchi L., Lolli G., Bottoni N., Oddone D. A controlled trial of acute and long term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol. 70:1992;339-342.
27. Moya A., Permanyer-Miralda G., Sagrista-Sauleda J., Carne X., Rius T., Mont L., Soler-Soler J. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope results of a controlled study of etilefrine versus placebo . J Am Coll Cardiol. 25:1995;65-69.
28. Calkins H. Pharmacologic approaches to therapy for vasovagal syncope. Am J Cardiol. 84:1999;20Q-25Q.
29. Grubb B.P., Kosinski D.J., Boehm K., Kip K. The postural orthostatic tachycardia syndrome a neurocardiogenic variant identified during head-up tilt table testing . PACE Pacing Clin Electrophysiol. 20:1997;2205-2212.
30. Narkiewicz K., Somers V.K. Chronic orthostatic intolerance part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? (Editorial.) Circulation. 98:1998;2105-2107.
31. Frohlich E.D., Tarazi R.C., Dustan H.P. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med. 123:1969;1-7.
32. Fouad F.M., Tadena-Thome L., Bravo E.L., Tarazi R.C. Idiopathic hypovolemia. Ann Intern Med. 104:1986;298-303.
33. Hoeldtke R.D., Davis K.M. The orthostatic tachycardia syndrome evaluation of autonomic function and treatment with octreotide and ergot alkaloids . J Clin Endocrinol Metab. 73:1991;132-139.
34. Streeten D.H., Anderson G.H.J., Richardson R., Thomas F.D. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function evidence for excessive venous pooling . J Lab Clin Med. 111:1988;326-335.
35. Low P.A., Opfer-Gehrking T.L., Textor S.C., Schondorf R., Suarez G.A., Fealey R.D., Camilleri M. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst. 50:1994;181-188.
36. Schondorf R., Low P.A. Idiopathic postural orthostatic tachycardia syndrome an attenuated form of acute pandysautonomia? Neurology. 43:1993;132-137.
37. Jankovic J., Gilden J.L., Hiner B.C., Kaufmann H., Brown D.C., Coghlan C.H., Rubin M., Fouad-Tarazi F.M. Neurogenic orthostatic hypotension a double-blind, placebo-controlled study with midodrine . Am J Med. 95:1993;38-48.
38. Low P.A., Gilden J.L., Freeman R., Sheng K.N., McElligott M.A. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension a randomized, double-blind multicenter study. Midodrine Study Group . JAMA. 277:1997;1046-1051.
39. Benditt D.G., Ferguson D.W., Grubb B.P., Kapoor W.N., Kugler J., Lerman B.B., Maloney J.D., Raviele A., Ross B., Sutton R., Wolk M.J., Wood D.L. Tilt table testing for assessing syncope American College of Cardiology . J Am Coll Cardiol. 28:1996;263-275.
40. Sutton R., Bloomfield D.M. Indications, methodology, and classification of results What do tilt-table tests tell us? Am J Cardiol. 84:1999;10Q-19Q.
41. Sra J., Maglio C., Biehl M., Dhala A., Blanck Z., Deshpande S., Jazayeri M.R., Akhtar M. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol. 8:1997;42-46.
42. Sheldon R. The role of pacing in the treatment of vasovagal syncope. Am J Cardiol. 84:1999;26Q-32Q.